Stock Taper
HSCSW
HEARTSCIENCES INC.
NASDAQ
$0.07
▲ UP 44.89% (0.02)

KEY STATISTICS

Market Cap$172.63 K
52w High$0.07
52w Low$0.04
Dividend Yield
Frequency
P/E
Volume3
Shares Out.2.65M

COMPANY

LEADERSHIP

Andrew Simpson
CHIEF EXECUTIVE
Andrew Simpson

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 15, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
14

UPCOMING EARNINGS

DateSep 10, 2026
DayThursday
Rev. Est.$100.00K
SEP
10
THU

PRICE

$0.07 ▲ UP 44.89% (+$0.02)
$0.06$0.06$0.069:35 AM9:54 AM10:12 AM10:31 AM10:50 AM11:08 AM11:27 AM0.07

About HeartSciences Inc.

https://heartsciences.com ↗

Heart Test Laboratories, Inc. develops cardiovascular diagnostic devices like the MyoVista wavECG for clinics, urgent care, and hospitals, providing advanced ECG solutions since 2007 in Southlake, Texas.

INDUSTRY

Medical - Devices

A PRODUCT HEARTSCIENCES INC. IS KNOWN FOR

MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device
MyoVista® Wavelet ECG (wavECG™) Cardiac Testing Device

The MyoVista® wavECG™ is an AI-powered 12-lead ECG device that detects subtle cardiac dysfunctions like diastolic issues, supporting early heart disease diagnosis through its cloud platform.

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

INSIDER TRADES

OFFICER: SEE REMARKS
Watson Danielle
Purchase · 25.0K shares
2026-07-07
DIRECTOR, OFFICER: SEE REMARKS
Simpson Andrew
Purchase · 425.0K shares
2026-06-22
DIRECTOR
Wells David R.
Purchase · 15.0K shares
2026-01-12
DIRECTOR
Bent Bruce
Purchase · 15.0K shares
2026-01-12

SECTORS PEERS

PEERPRICE
MOVE$14.40COMPARE
NDRA$6.17COMPARE
GCTK$3.02COMPARE
SHPH$3.46COMPARE
BBLG$0.57COMPARE
BJDX$0.83COMPARE